Stay updated on Resmetirom in NASH and Fibrosis Clinical Trial

Sign up to get notified when there's something new on the Resmetirom in NASH and Fibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Resmetirom in NASH and Fibrosis Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-17T22:00:29.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The site footer revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T22:00:24.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study content and blocking access to the MAESTRO-NASH (NCT03900429) study details.
    Difference
    17%
    Check dated 2026-09-19T20:42:59.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    A new reference has been added to Publications: HRQL assessments in a 52-week, double-blind, randomized phase III study of resmetirom (MGL-3196) in NASH with fibrosis (MASH), published in Hepatology 2025. This addition provides context on patient-reported outcomes within the MAESTRO-NASH program.
    Difference
    0.0%
    Check dated 2026-08-29T19:02:02.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    Revision updated from v3.6.4 to v3.6.5, indicating a new deployed version of the page metadata. The change appears to be administrative and does not alter study details or user-facing functionality.
    Difference
    0.0%
    Check dated 2026-08-08T11:07:08.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    A new citation for Schattenberg JM et al. on qFibrosis regression with resmetirom was added to the Publications section, and the previous online-ahead-of-print citation was removed.
    Difference
    0.0%
    Check dated 2026-08-01T08:37:41.000Z thumbnail image

Stay in the know with updates to Resmetirom in NASH and Fibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Resmetirom in NASH and Fibrosis Clinical Trial page.